ADRB2 E27Q - GET-Evidence

About Genomes Guides Recent changes Contributors Download

Note: This variant has not been sufficiently evaluated by a GET-Evidence editor.

To be considered sufficiently evaluated a variant must have both "variant evidence" and "clinical importance" scores filled in.

Please help improve GET-Evidence by evaluating evidence for this variant!

Curation:
Currentness:

(See the latest version)

ADRB2 E27Q

(ADRB2 Glu27Gln)


You are viewing an old version of this page that was saved on March 29, 2011 at 8:55pm by Genome Importing Robot.

Short summary

 

Variant evidence
Computational -
Functional -
Case/Control -
Familial -
 
Clinical importance
Severity -
Treatability -
Penetrance -
 

Impact

Insufficiently evaluated pharmacogenetic

(The "insufficiently evaluated" qualifier is assigned automatically based on the above evidence and importance scores.)

Inheritance pattern

unknown

Summary of published research, and additional commentary

 

Allele frequency

  • C @ chr5:148206473: 66.1% (7115/10758) in EVS
  • C @ chr5:148186665: 65.6% (80/122) in GET-Evidence
  • Frequency shown in summary reports: 66.1% (7115/10758)

Publications
 

Genomes
 

hu034DB1 - CGI sample GS00253-DNA_A02_200_37
het C @ chr5:148206473

 

hu04FD18 - CGI sample GS00253-DNA_F01_200_37
het C @ chr5:148206473

 

hu3215A7 - PGP12 (hu3215A7) build 36, substitution variants, hu3215A7 build 36 substitution variants
hom C @ chr5:148186666

 

hu604D39 - CGI sample GS00253-DNA_B02_200_37
hom C @ chr5:148206473

 

hu728FFF - PGP11 (hu728FFF) build 36, substitution variants, hu728FFF build 36 substitution variants
het C @ chr5:148186666

 

hu9385BA - CGI sample GS00253-DNA_E01_200_37
het C @ chr5:148206473

 

huAE6220 - CGI sample GS00253-DNA_H01_200_37
hom C @ chr5:148206473

 

huE80E3D - CGI sample GS00253-DNA_D01_200_37
hom C @ chr5:148206473

 

GS06994 - var-GS06994-1100-36-ASM
hom C @ chr5:148186666

 

GS10851 - var-GS10851-1100-36-ASM
het C @ chr5:148186666

 

GS12004 - var-GS12004-1100-36-ASM
hom C @ chr5:148186666

 

GS18501 - var-GS18501-1100-36-ASM
hom C @ chr5:148186666

 

GS18502 - var-GS18502-1100-36-ASM
hom C @ chr5:148186666

 

GS18504 - var-GS18504-1100-36-ASM
het C @ chr5:148186666

 

GS18505 - var-GS18505-1100-36-ASM
het C @ chr5:148186666

 

GS18508 - var-GS18508-1100-36-ASM
hom C @ chr5:148186666

 

GS18517 - var-GS18517-1100-36-ASM
hom C @ chr5:148186666

 

Added in this revision:

GS18526 - var-GS18526-1100-36-ASM
hom C @ chr5:148186666

 

NA07022

 

NA12156

 

NA12878

 

NA18507

 

NA18517

 

NA18555

 

NA18956

 

NA19129

 

NA19240

 

snp-1

 

snp-18

 

snp-2

 

snp-27

 

snp-28

 

snp-29

 

snp-3

 

snp-31

 

snp-5

 

snp-6

 

Other external references
 

    dbSNP
  • rs1042714
    www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi
    PharmGKB
  • [Asthma; Heart Diseases]
    This variant has been studied in terms of asthma and its drug response and in terms of heart disease and vascular phenotypes and their drug responses.
    www.pharmgkb.org/search/annotatedGene/adrb2/
  • [Heart Failure]
    [carvedilol]
    Heart failure patients homozygous for Gln27 were less likely to have improved left ventricular ejection fraction after carvedilol treatment compared to Glu27 carriers. However, in another study of heart failure patients, Gln27Glu polymorphism was not associated with the improvement of left ventricular ejection fraction or decrease in heart rate due to a beta blocker in stable congestive heart failure.
    www.ncbi.nlm.nih.gov/pubmed/12835612; PubMed ID:15861037
  • [Asthma]
    Three recent meta-analyses have shown that the Gln27Glu and Gly16Arg polymorphisms are not associated with asthma.
    www.ncbi.nlm.nih.gov/pubmed/15153795; PubMed ID:15867853; PubMed ID:15987731
    PolyPhen-2
  • Score: 0.001 (benign)

Other in silico analyses
 

  • NBLOSUM100 score = –2
  • GET-Evidence autoscore = 3

Edit history
 

Gene search

"GENE" or "GENE A123C":

Log in



Data available under CC0. Web application © 2010-2014 Curoverse, Inc.